<DOC>
	<DOCNO>NCT01893658</DOCNO>
	<brief_summary>The investigator goal evaluate role XOLAIR® treatment Acute Tubulointerstitial Nephritis ( AIN ) goal shorten duration dose prednisone treatment drug-induced AIN . Currently good treatment drug-induced AIN . Prednisone standard treatment associate many side-effects use long-term high dos .</brief_summary>
	<brief_title>Xolair ( Omalizumab ) Treatment Drug-induced Acute Tubulointerstitial Nephritis ( AIN )</brief_title>
	<detailed_description />
	<mesh_term>Nephritis</mesh_term>
	<mesh_term>Nephritis , Interstitial</mesh_term>
	<mesh_term>Prednisone</mesh_term>
	<mesh_term>Omalizumab</mesh_term>
	<criteria>1 . Adult subject &gt; 18 year old gender 2 . Biopsy proven acute interstitial nephritis native kidney without evidence ischemic glomerular pathology biopsy 3 . Normal baseline creatinine define estimate GFR ≥ 60 ml/min/SA base MDRD calculation within 1 year prior renal biopsy 4 . Serum creatinine elevation &gt; 0.3 mg/dL and/or double serum creatinine compare recent documented creatinine available ( least within last year ) 5 . No immunosuppressant last three month include prednisone 6 . Women childbearing potential use contraception method include one time dose know longterm effect . 1 . Unwillingness give consent 2 . Patients Pregnant ( positive serum pregnancy test female ) breast feed 3 . Documented history autoimmune disease 4 . Inability unwillingness take prednisone prescribe duration and/or dose 5 . Subjects suspect nondruginduced AIN 6 . Subjects meet inclusion criterion 7 . Subjects contraindication administration omalizumab 8 . Prior use omalizumab 9 . Severe hypersensitivity omalizumab component product 10 . Known elevate IgE level disease process 11 . Subjects take ( nonsteroidal antiinflammatory drug ) NSAIDs chronically 12 . Use investigational agent last 30 day 13 . Patients severe medical condition ( ) include metastatic cancer , terminal congestive heart failure , severe ischemic heart disease medical condition life expectancy le 6 month .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2016</verification_date>
	<keyword>Interstitial Nephritis</keyword>
	<keyword>Nephritis</keyword>
	<keyword>Tubulointerstitial</keyword>
	<keyword>Renal disease</keyword>
	<keyword>Kidney</keyword>
</DOC>